Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Transcode Therapeutics Inc (RNAZ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Transcode Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.5250 +0.0851    +19.35%
25/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
0.5335
+0.0085
+1.6191%
9:33:51 - Real-time Data
  • Volume: 1,236,678
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.4395 - 0.5380
Type:  Equity
Market:  United States
Transcode Therapeutics 0.5250 +0.0851 +19.35%

Transcode Therapeutics Company Profile

 
Read the Transcode Therapeutics Inc company profile to learn more about the business and the management team. View Transcode Therapeutics Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

19

Equity Type

ORD

TransCode Therapeutics, Inc., a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. Its lead therapeutic candidate is TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. The company is also developing TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; and TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. In addition, the company developing TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.

Contact Information

Address 6 Liberty Square Suite 2382
Boston, 02109
United States
Phone 857 837 3099
Fax -

Top Executives

Name Age Since Title
Anna Moore 61 2016 Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
Dejan Juric - 2021 Member of Advisory Board
Raghu Kalluri - - Member of Advisory Board
Oliver Steinbach - - Member of Advisory Board
G. Susan Srivatsa - - Member of Advisory Board
Keith T. Flaherty 53 - Member of Advisory Board
George Calin - - Member of Advisory Board
Raul Mostoslavsky - - Member of Advisory Board
Magda Marquet 65 2021 Independent Director
Erik Manting 53 2020 Independent Director
Betsabeh Madani Hermann - - Member of Advisory Board
Lubomir Nechev - 2021 Member of Advisory Board
Philippe P. Calais 65 2018 Executive Chairman of the Board
Dmitry Samarsky 57 - Member of Advisory Board
Mehmet Yigit - - Member of Advisory Board
Jerome M. Lewis 75 - Member of Advisory Board
John B. Henneman 62 - Member of Advisory Board
Frank J. Slack - 2022 Member of Advisory Board
Thomas A. Fitzgerald 72 2018 Interim CEO, CFO, President, VP of Administration & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RNAZ Price Commentary

Write your thoughts about Transcode Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email